
Antimicrobial Resistance — What Every Obstetrician Can Do
Bacterial AMR directly caused 1.14 million deaths and was associated with 4.71 million in 2021 [1]
Without action, about 39 million deaths are forecast from 2025 to 2050; South Asia carries the largest share, 11.8 million [1]
In India, most E. coli are now resistant to cefotaxime, ceftazidime, ciprofloxacin and levofloxacin (under 20% susceptible) [2]
Carbapenem susceptibility of K. pneumoniae fell to about 36 to 38% in 2023 [2]
Infections around childbirth cause about one in ten maternal deaths [4]; resistant organisms make them harder to treat
WHO AWaRe: use Access antibiotics first; aim for 70% of all use by 2030 [3]
| Measure | Figure [1] |
|---|---|
| Deaths attributable to AMR, 2021 | 1.14 million; 1.91 million forecast for 2050 |
| Deaths associated with AMR, 2021 | 4.71 million; 8.22 million forecast for 2050 |
| Children under 5, 1990 to 2021 | Deaths fell about 50%, from vaccines and sanitation |
| Adults 70 and over, 1990 to 2021 | Deaths rose over 80% |
| Carbapenem-resistant Gram-negatives | 127,000 deaths (1990) to 216,000 (2021): the largest rise |
| MRSA | 57,200 deaths (1990) to 130,000 (2021) |
| What could be saved by 2050 | 92 million lives with better care and access; 11 million with new Gram-negative drugs |
E. coli was the most persistent pathogen across outpatients, wards and ICUs; under 20% susceptible to cefotaxime, ceftazidime, ciprofloxacin and levofloxacin [2]
Piperacillin-tazobactam and amikacin susceptibility also fell (56.8% to 42.4%; 79.2% to 68.2%), probably for E. coli; the reports read do not say clearly [2]
Pseudomonas carbapenem resistance rose to 35 to 39% [2]; check the original report, as one news report may contain an error
Your own hospital’s antibiogram matters more than national averages; ask your laboratory for it yearly (from memory)
Use: make Access the default; restrict Watch; protect Reserve with approval or specialist advice [3]
The WHO AWaRe Antibiotic Book gives first- and second-choice drugs, doses and durations for common infections [3]
Updated every two years with the WHO Essential Medicines List; the 2023 edition covers over 250 antibiotics [3]
| Rule | Detail |
|---|---|
| Caesarean [4] | Single dose of a first-generation cephalosporin or penicillin, 30 to 60 minutes before skin incision; adapt to local resistance |
| Timing [5] | Short-acting agents (cefazolin) within 60 minutes before incision; vancomycin started 15 minutes or more before |
| Redose [5] | After two half-lives (4 hours for cefazolin), long delays, or blood loss over 1.5 L |
| Duration [5] | One preoperative dose is usually enough for caesarean and gynaecological surgery; do not continue because a drain is in |
| Operative vaginal birth [4] | Routine single dose: amoxicillin 1 g plus clavulanic acid 200 mg IV within 6 hours of birth |
| Manual removal of placenta; third- or fourth-degree tear [5] | Prophylaxis recommended |
Not needed: uncomplicated vaginal birth, meconium-stained liquor, or ruptured membranes beyond 36 weeks without other indication [5]
Indian practice: multi-day postoperative courses after caesarean are still common; they add resistance without benefit (from memory)
| Principle | In practice |
|---|---|
| Culture first | Urine before treating UTI; blood and swabs in sepsis; do not delay treatment in sepsis (from memory) |
| Access first [3] | Nitrofurantoin, cefalexin or amoxicillin by culture for lower UTI; avoid fluoroquinolones in pregnancy (from memory) |
| Review [5] | Switch IV to oral as soon as clinically feasible; stop if infection is excluded |
| Right duration [5] | No longer than needed to control or prevent infection |
| Penicillin allergy [5] | Take a careful history; low-risk reactions can have a cephalosporin; refer for delabelling; up to 80% lose IgE sensitivity over time |
| GBS with severe allergy [5] | Vancomycin preferred; clindamycin only if the isolate is susceptible |
Hand hygiene: Semmelweis cut puerperal mortality from over 10% to 2% in the 1840s [5]
Vaginal cleansing before caesarean: povidone-iodine 1 to 10% or chlorhexidine 0.05 to 0.25% for 30 seconds; never alcohol-based [4]
Skin preparation: 2% chlorhexidine in 70% alcohol preferred; povidone-iodine if unavailable [4]
Aseptic technique, PPE, contact precautions; routine resistant-organism screening of obstetric patients is not recommended [5]
Fewer vaginal examinations in labour and clean birth practices (from memory)
Vaccination (tetanus, influenza, COVID-19 in pregnancy) prevents infections that lead to antibiotic use (from memory)
Antibiotics do not treat colds, flu or most fevers (from memory)
Take them only as prescribed; do not save leftovers or share them (from memory)
Do not buy antibiotics without a prescription (from memory)
Wash hands, especially before feeding the baby and after the toilet (from memory)
Five days of antibiotics after every caesarean [4][5]
Ceftriaxone as the default for everything; it is a Watch drug [3]
Treating a fever without a source or a culture
Never stopping: no review date written on the chart
Accepting a “penicillin allergy” label without asking what happened [5]
Ignoring the local antibiogram when choosing empirical therapy [4]
AWARE
| Abbreviation | Meaning |
|---|---|
| AMR | Antimicrobial resistance |
| AMRSN | ICMR Antimicrobial Resistance Research and Surveillance Network |
| AWaRe | WHO Access, Watch and Reserve classification of antibiotics |
| GBS | Group B streptococcus |
| GRAM | Global Research on Antimicrobial Resistance project |
| ICMR | Indian Council of Medical Research |
| ICU | Intensive care unit |
| IgE | Immunoglobulin E; the antibody behind immediate allergy |
| MRSA | Meticillin-resistant Staphylococcus aureus |
| PPE | Personal protective equipment |
| UTI | Urinary tract infection |
| WHO | World Health Organization |
[1] GRAM Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 2024. (Read through the University of Oxford news release, 17 September 2024.)
[2] Indian Council of Medical Research. AMRSN annual report 2023 (data January to December 2023). (Read through Down To Earth, 10 September 2024, and BW Healthcare World.)
[3] World Health Organization. AWaRe classification of antibiotics, 2023 (WHO/MHP/HPS/EML/2023.04), and the AWaRe Antibiotic Book. (Read through a Microbe Online summary.)
[4] AlignMNH. New guidance: updated WHO recommendations on the prevention and treatment of maternal peripartum infections. Synthesis brief, June 2021.
[5] Antimicrobial stewardship and infection prevention. O&G Magazine (RANZCOG) 2019;21(4).


